DELPhI Evaluation of Psychiatric Conditions
NCT03842345 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2022-03-03
Summary
DELPhI acquisition and analysis software, a QuantalX Neuroscience development, which is designed to measure, analyze, and display brain electrical activity of human electroencephalogram (EEG), to transcranial magnetic stimulation (TMS), will be used to evaluate different psychiatric conditions.
Conditions
- Major Depressive Disorder
- Bi-Polar Disorder
- ADHD
- Schizophrenia
- OCD
- Ptsd
- Healthy
Sponsors & Collaborators
-
QuantalX Neuroscience
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-31
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
More Related Trials
-
Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls
NCT01570426 ·Status: UNKNOWN
-
The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
NCT04433845 ·Status: UNKNOWN ·Phase: PHASE2
-
Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation
NCT00801567 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
NCT01663974 ·Status: TERMINATED
-
Ceftriaxone in the Management of Bipolar Depression
NCT00566111 ·Status: TERMINATED ·Phase: NA
-
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
NCT06429722 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
NCT06093451 ·Status: RECRUITING ·Phase: PHASE4
-
Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolar Disorder
NCT03206463 ·Status: TERMINATED ·Phase: PHASE1
-
Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
NCT03829787 ·Status: RECRUITING
-
The Effect of Methylphenidate on Cognitive Abilities of Adults With Bipolar Disorder
NCT02020200 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression
NCT00622245 ·Status: TERMINATED ·Phase: PHASE2
-
Imaging 5HT7 Antagonist Effects in Bipolar Disorder
NCT03633357 ·Status: UNKNOWN ·Phase: NA
-
Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
NCT01784341 ·Status: COMPLETED
-
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
NCT00596622 ·Status: COMPLETED ·Phase: PHASE4
-
Depakote-ER for Depressive and Bipolar Depression
NCT00226343 ·Status: COMPLETED ·Phase: PHASE4
-
Copeptin in Outcome Prediction of an Acute Psychotic Episode
NCT03235908 ·Status: COMPLETED
-
Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression
NCT01051440 ·Status: TERMINATED ·Phase: PHASE4
-
Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder
NCT04058249 ·Status: TERMINATED ·Phase: NA
-
Testing the Value of Smartphone Assessments of People With Mood Disorders
NCT03429361 ·Status: COMPLETED
-
Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
NCT00457054 ·Status: COMPLETED ·Phase: PHASE4
-
Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
NCT00545675 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Genetic and Environmental Factors of Vulnerability in Bipolar Disorders
NCT02627404 ·Status: UNKNOWN ·Phase: NA
-
Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness
NCT06641726 ·Status: RECRUITING
-
PET and MRI Brain Imaging of Bipolar Disorder
NCT01880957 ·Status: COMPLETED ·Phase: NA
-
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
NCT03257865 ·Status: COMPLETED ·Phase: PHASE3